ACT-1 [Human thyroid carcinoma]-GFP-LUC
![ACT-1 [Human thyroid carcinoma]-GFP-LUC](/assets/front/img/loading.gif?v=1.0.762)
Cat.No.:
EDJ-GLQ0316
Species:
Human
Cell Name:
ACT-1 [Human thyroid carcinoma]
Size:
1×10⁶cells
ACT-1 [Human thyroid carcinoma]-GFP-LUC Cell Line meets our QC standard. Low passage, high activity, contamination free. Useful for various vitro studies.
| Cat.No. | EDJ-GLQ0316 |
|---|---|
| Product Name | ACT-1 [Human thyroid carcinoma]-GFP-LUC |
| Species | Human |
| Cell Line | ACT-1 [Human thyroid carcinoma] |
| Cellosaurus ID | CVCL_6291 |
| Cell Line Synonyms | ACT1 |
| Passage Ratio | 1:3,3-4 days |
| Complete Culture Medium | RPMI 1640 +5% FBS |
| Freezing Medium | 90% complete culture medium+ 10% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: ACT-1 [Human thyroid carcinoma] | STR Info (Cell bank) Cell Line: ACT-1 [Human thyroid carcinoma] | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1PO | 11 | 12 | 11 | 12 |
| D2S1338 | 19 | 22 | ||
| D3S1358 | 16 | 16 | ||
| D5S818 | 11 | 13 | 11 | 13 |
| D7S820 | 10 | 11 | 10 | 11 |
| D8S1179 | 11 | 14 | 11 | 14 |
| D13S317 | 10 | 12 | 10 | 12 |
| D16S539 | 9 | 11 | 9 | 11 |
| D18S51 | 15 | 16 | 15 | 16 |
| D19S433 | 14 | |||
| D21S11 | 30 | 31 | 30 | 31 |
| FGA | 23 | 24 | 23 | 24 |
| Penta D | 9 | 11 | ||
| Penta E | 12 | 18 | ||
| TH01 | 6 | 9 | 6 | 9 |
| TPOX | 8 | 8 | ||
| vWA | 17 | 18 | 17 | 18 |
| D65J043 | 12 | 14 | ||
| D12S391 | 18 | 20 | ||
| D2S441 | 11 | 12 | ||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
